Sequenom Receives $2.2M to Study Genomic Underpinnings of Blood Disease | GenomeWeb

NEW YORK, Nov. 8 – Sequenom said Thursday it received a $2.2 million grant from the National Institutes of Health to conduct a genome-wide disease association study.

Sequenom of San Diego said it will use its MassArray technology and 100,000 SNP assays to look for genetic variations among people with the blood disease beta-thalassemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.